Guiding multi-modal therapies against MRD by liquid biopsies
Project factsheets
Learn more about the projects supported by IHI as well as the Innovative Medicines Initiative (IMI).
Displaying 21 projects and 1 programmes
Integration of heterogeneous data and evidence towards regulatory and HTA acceptance
Imaging and advanced guidance for workflow optimization in interventional oncology
Big Data for Better Outcomes
H2O Health outcomes observatory
Healthcare alliance for resourceful medicines offensive against neoplasms in hematology
Healthcare alliance for resourceful medicines offensive against neoplasms in hematology – PLUS
Integrated immunoprofiling of large adaptive cancer patients cohorts
Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
ITCC pediatric preclinical POC platform
Optimal treatment for patients with solid tumours in Europe through artificial intelligence
Building a reproducible single-cell experimental workflow to capture tumour drug persistence
Prostate cancer diagnosis and treatment enhancement through the power of big data in Europe
Proton versus photon therapy for esophageal cancer - a trimodality strategy
Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials
Accelerating development and improving access to CAR and TCR-engineered T cell therapy
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
European Bank for induced pluripotent Stem Cells
Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis
Methods for systematic next generation oncology biomarker development
New models for preclinical evaluation of drug efficacy in common solid tumours
Quantative imaging in cancer:connecting cellular process with therapy
